Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema
about
Aquaporin 4 and neuromyelitis opticaImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis opticaOptic neuritis in neuromyelitis optica.[Ultrahigh field MRI in context of neurological diseases].Transient hyperckemia in the setting of neuromyelitis optica (NMO).Experimental models of neuromyelitis optica.Neuromyelitis optica IgG causes placental inflammation and fetal death.NMDA receptor antibodies associated with distinct white matter syndromes.Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis opticaSeverely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsComplement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.Greatly improved survival and neuroprotection in aquaporin-4-knockout mice following global cerebral ischemia.Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgGT cell-activation in neuromyelitis optica lesions plays a role in their formation.Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G.Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica.Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies.Mechanisms for lesion localization in neuromyelitis optica spectrum disorders.The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.Paraneoplastic NMOSD associated with EG junction adenocarcinoma expressing unprotected AQP4.
P2860
Q24613666-C0E2D15C-DEA8-4CE5-B1B8-1D8FD2416B46Q27016045-EB844588-9E77-4A4E-90D4-B4E78C94CA4EQ27021535-2AE62C4D-8553-4AD0-9F5B-CBE896CB8D4EQ30610471-16BF256C-2F67-4AF5-ACF2-4286DB4FCE92Q30759627-1D0D4091-C914-4B9C-B2F6-1A4165603929Q30826839-C3A2B16C-A0E4-449B-8BE2-B80DEDF97C39Q33785380-40C725BC-59E5-491C-BD47-F85B59B21A00Q34168084-1C445B2A-4955-4E5F-A08D-21205778747CQ34368624-4819DE0F-2E47-4FF1-B174-92093F4C156FQ34377212-112CFEC1-118F-4921-952E-4EFA6367BF83Q34529121-B2F30A03-94B2-411F-921E-AAC627BB9B77Q35013113-0D7FB13C-A4D3-4EF6-BD2D-339D87AB8046Q35052199-A7F5CDC6-CE85-460F-8CB4-508ADE25C1CBQ35067939-D6FB5D23-A8DF-436B-9960-14E78AA18F3BQ36348690-A070D039-E3E6-4033-8105-440B1348E341Q36515512-E1B1AF0D-78A5-4635-8178-62505CFD52F5Q36635664-3E069938-39EB-4AC3-BEDE-3CF55B9C1E23Q36648907-A49B1266-1DD7-4E31-9EEC-9249FBC02F86Q36744223-41B77D9C-D313-40F0-9CE9-7370248AEED2Q36911907-420FB5B5-A79C-4384-9BE9-1F614A7B210FQ37180238-87220A01-18FE-4930-9D7D-BCC32239193CQ37353732-404BD1CD-282E-4EFE-A438-1206067300E9Q37472990-98F2C92D-CA82-4CC7-A8E8-9C7661D61FF4Q37503646-08A0C3E1-A453-4364-92F8-5992EF109C71Q37638498-CD7BF2B0-5CA0-4941-84DF-80B5B594F05AQ39039987-4E6EBBB6-AF13-4809-8634-48C68D8CBCD3Q41163269-7746A5FA-5B5F-474F-A8EA-811420DF988AQ42137460-41BA1B31-E198-4616-8A9C-ADE8AF28F5A9Q42560864-3052633D-91A8-43A4-942D-44F18634A8ADQ42844764-54B80552-918B-4965-9028-B2614161F29DQ48876160-53765523-F1F6-40FB-B4E3-C81DE6A69061Q49713173-7FB91CA7-FD5C-41DE-8C14-47D4B71BA934Q49830505-5A2A5861-04FA-4BE9-84E9-F9A1F856990EQ52603606-97F74F7D-8E48-4914-9558-881BA09281C6Q55606632-5F19A09C-8996-4F39-8391-31CE9CB4D938
P2860
Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intravenous neuromyelitis opti ...... heral organs and area postrema
@ast
Intravenous neuromyelitis opti ...... heral organs and area postrema
@en
Intravenous neuromyelitis opti ...... heral organs and area postrema
@nl
type
label
Intravenous neuromyelitis opti ...... heral organs and area postrema
@ast
Intravenous neuromyelitis opti ...... heral organs and area postrema
@en
Intravenous neuromyelitis opti ...... heral organs and area postrema
@nl
prefLabel
Intravenous neuromyelitis opti ...... heral organs and area postrema
@ast
Intravenous neuromyelitis opti ...... heral organs and area postrema
@en
Intravenous neuromyelitis opti ...... heral organs and area postrema
@nl
P2093
P2860
P1433
P1476
Intravenous neuromyelitis opti ...... heral organs and area postrema
@en
P2093
A S Verkman
Jeffrey L Bennett
Julien Ratelade
P2860
P304
P356
10.1371/JOURNAL.PONE.0027412
P407
P577
2011-11-04T00:00:00Z